Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism Disorders

Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.

3,309 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism Disorders trial results

Completed

Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia

NCT01327014

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Robert Karns, MD A Medical Corporation Beverly Hills, California, United States
  • Jellinger and Lerman, MD Hollywood, Florida, United States
  • Department of Internal Medicine, University of Kansas Medical Center Kansas City, Kansas, United States
  • Harold E Bays, MD Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

NCT01458977

Conditions
Dyslipidemia, Dyslipidemias, HIV, +3 more
Locations
  • Germans Trias i Pujol Hospital Badalona, Barcelona, Spain
  • Hospital Valle Hebrón Barcelona, Spain
  • Hospital de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
View Trial Details
Completed

Fed Bioequivalence Study of CBZ Formulations

NCT02132897

Conditions
Bio-equivalence Study, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +10 more
Locations
  • Center for Clinical Pharmacology Research Bdbeq S.A. Italian Hospital Montevideo, Montevideo Department, Uruguay
View Trial Details
Completed

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

NCT01200160

Conditions
Behavior, Cardiovascular Diseases, Dyslipidemias, +6 more
Locations
  • Site Reference ID/Investigator# 48183 Cali, Colombia
  • Site Reference ID/Investigator# 48182 Cali, Colombia
  • Site Reference ID/Investigator# 42108 Aguascalientes, Mexico
  • Site Reference ID/Investigator# 42110 Aguascalientes, Mexico
View all 22 locations
View Trial Details

Related conditions